![GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] logo](http://a248.e.akamai.net/7/248/90997/20120131170242/www.gardasil.com/assets/content/print-friendly/logo.jpg){kind=logo}
Want a free information kit?
If you're interested in receiving a free information kit about GARDASIL for yourself or to share with others, please enter your information below and click the "Submit" button at the bottom of this page.
Tell us about yourself:
The information you provide will be available to the Merck & Co., Inc., family of companies (collectively, "Merck") and others working on behalf of Merck, and according to the same standards, to provide the information and services you request. Personal information about you will not otherwise be disclosed for marketing purposes without your permission. Merck reviews personal information and nonidentifiable information not only to provide the requested information and services but also to develop and offer additional services and communications that we believe our customers might find of interest. Merck also may use personal information to audit its resources for compliance and security purposes. For more information about how Merck protects personal information about you, please read Merck's Internet Privacy Policy and Privacy Statement for U.S. Patients, Consumers, and Caregivers.
| Back to top of page | |
INFORMATION ABOUT GARDASILGARDASIL is the only human papillomavirus (HPV) vaccine that helps protect against 4 types of HPV. In girls and young women ages 9 to 26, GARDASIL helps protect against 2 types of HPV that cause about 75% of cervical cancer cases, and 2 more types that cause 90% of genital warts cases. In boys and young men ages 9 to 26, GARDASIL helps protect against 90% of genital warts cases. GARDASIL also helps protect girls and young women ages 9 to 26 against 70% of vaginal cancer cases and up to 50% of vulvar cancer cases. GARDASIL may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV. GARDASIL does not prevent all types of cervical cancer, so it’s important for women to continue routine cervical cancer screenings. GARDASIL does not treat cancer or genital warts. GARDASIL is given as 3 injections over 6 months. |
IMPORTANT SAFETY INFORMATIONAnyone who is allergic to the ingredients of GARDASIL, including those severely allergic to yeast, should not receive the vaccine. GARDASIL is not for women who are pregnant. The side effects include pain, swelling, itching, bruising, and redness at the injection site, headache, fever, nausea, dizziness, vomiting, and fainting. Fainting can happen after getting GARDASIL. Sometimes people who faint can fall and hurt themselves. For this reason, your health care professional may ask you to sit or lie down for 15 minutes after you get GARDASIL. Some people who faint might shake or become stiff. This may require evaluation or treatment by your health care professional. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Read the Patient Product Information or the Prescribing Information for GARDASIL. |
This site is intended only for residents of the United States, its territories, and Puerto Rico.
Copyright © 1995-2011 Merck & Co., Inc. All rights reserved.
20950185(14)-12/09-GRD
This site is intended only for residents of the United States, its territories, and Puerto Rico.
